UBE2G2

Ubiquitin-conjugating enzyme E2 G2 · P60604 · UBE2G2 on Sugi Atlas →

0 patent compounds predicted against UBE2G2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to UBE2G2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis PHASE2/PHASE3UNKNOWN
Does Watercress Intake Have an Impact on Cancer Patients Outcomes: a Longitudinal Trial PHASE3UNKNOWN
Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer PHASE2COMPLETED
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer PHASE2UNKNOWN
Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer PHASE2UNKNOWN
Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With Integrated Biomarker Analysis PHASE2ACTIVE_NOT_RECRUITING
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects PHASE1/PHASE2COMPLETED
A Phase 1/2 Trial of SRA737 in Subjects With Advanced Cancer PHASE1/PHASE2COMPLETED
Bortezomib in Treating Patients With Advanced or Metastatic Sarcoma PHASE2COMPLETED
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies PHASE1/PHASE2RECRUITING
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer PHASE1/PHASE2COMPLETED
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck PHASE1COMPLETED
Studying TAK-243 in Patients With Advanced Cancer PHASE1RECRUITING
WEE1 Inhibitor MK-1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck PHASE1COMPLETED
Endocrine Disruptors and Life STILe in Breast Cancer Development nanUNKNOWN
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis nanUNKNOWN
Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria nanCOMPLETED
Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC) nanUNKNOWN
Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors nanNOT_YET_RECRUITING
The IMPACT Study - Identification of Men With a Genetic Predisposition to ProstAte Cancer nanACTIVE_NOT_RECRUITING
S9313B Study of Tumor Tissue Samples From Women With Early-Stage Breast Cancer Enrolled on Clinical Trial SWOG-9313 nanCOMPLETED
The Role of RING Ubiquitin Ligases in Biologic and Oncologic Processes in Tissues of Mesenchymal Origin nanUNKNOWN
Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders nanRECRUITING
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma nanCOMPLETED
Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype nanRECRUITING
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary nanUNKNOWN
Establishment of a Prospective Clinical-biological Database nanRECRUITING
Study of Proteins in Head and Neck Cancer Cells nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a UBE2G2 binder may also engage these)

ProteinNameSimilarity
P60605 1.000 P60605 →
Q5RF84 1.000 Q5RF84 →
Q17QG5 1.000 Q17QG5 →
Q42540 0.997 Q42540 →
P42747 0.996 P42747 →
P62253 0.996 P62253 →
O00102 0.995 O00102 →
P62255 0.995 P62255 →
P62254 0.995 P62254 →
Q42541 0.994 Q42541 →
Q4R5Y8 0.994 Q4R5Y8 →
P34477 0.988 P34477 →
Q02159 0.988 Q02159 →
Q9XWF6 0.987 Q9XWF6 →
P35128 0.987 P35128 →
Q9Y818 0.986 Q9Y818 →
Q95XX0 0.986 Q95XX0 →
P52487 0.985 P52487 →
P63281 0.984 P63281 →
P63280 0.984 P63280 →
Q2EF73 0.984 Q2EF73 →
Q28CQ4 0.984 Q28CQ4 →
P63283 0.984 P63283 →
P61080 0.984 P61080 →
Q4WLA7 0.984 Q4WLA7 →
Q5R7J6 0.984 Q5R7J6 →
P61079 0.984 P61079 →
Q5R4V7 0.984 Q5R4V7 →
Q06AA9 0.984 Q06AA9 →
P61087 0.983 P61087 →